JESSIE LEEPER: Open Payments
NPI 1770253692 · CEDAR RAPIDS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,110 in 52 payments from 17 companies in 2025. Trend: 2023 $471 · 2024 $1,298 · 2025 $1,110
Food & beverage: $1,110
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $244 |
| ABBVIE INC. | 11 | $162 |
| Madrigal Pharmaceuticals | 3 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $105 |
| Lilly USA, LLC | 4 | $85 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $81 |
| Celltrion USA Inc. | 4 | $71 |
| Ipsen Biopharmaceuticals, Inc | 2 | $51 |
| QOL Medical, LLC | 2 | $31 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
Products named: TREMFYA, REZDIFFRA, OMVOH, XIFAXAN, VEGZELMA, ENTYVIO, SKYRIZI, IQIRVO.
Industry payments across IA — which companies pay providers there.
